IMIngrid Martí-Pàmies

Ingrid Martí-Pàmies

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ingrid Martí-Pàmies has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Sex-Specific Effects of MTSS1 Downregulation on Dilated Cardiomyopathy

    by Dongwook Choe, Megan Burke, Jeffrey A. Brandimarto, Ingrid Marti-Pamies, Jaime Yob, Yifan Yang, Michael P. Morley, Theodore G. Drivas, Sharlene Day, Michael Levin, et al.


  • Brown Adipose Tissue and BMP3b Decrease Injury in Cardiac Ischemia-Reperfusion

    by Íngrid Martí-Pàmies, Robrecht Thoonen, Michael Morley, Lauren Graves, Jesus Tamez, Alex Caplan, Kendra McDaid, Vincent Yao, Allyson Hindle, Robert E. Gerszten, et al.

    BACKGROUND: Despite advances in treatment, myocardial infarction (MI) is a leading cause of heart failure and death worldwide, with both ischemia and reperfusion (I/R) causing cardiac injury. A previous study using a mouse model of nonreperfused MI showed activation of brown adipose tissue (BAT). Recent studies showed that molecules secreted by BAT target the heart. We investigated whether BAT attenuates cardiac injury in I/R and sought to identify potential cardioprotective proteins secreted by BAT. METHODS: Myocardial I/R surgery with or without BAT transplantation was performed in wild-type (WT) mice and in mice with impaired BAT function (uncoupling protein 1 [ Ucp1 ]–deficient mice). To identify potential cardioprotective factors produced by BAT, RNA-seq (RNA sequencing) was performed in BAT from WT and Ucp1 −/− mice. Subsequently, myocardial I/R surgery with or without BAT transplantation was performed in Bmp3b (bone morphogenetic protein 3b)–deficient mice, and WT mice subjected to myocardial I/R were treated using BMP3b. RESULTS: Dysfunction of BAT in mice was associated with larger MI size after I/R; conversely, augmenting BAT by transplantation decreased MI size. We identified Bmp3b as a protein secreted by BAT after I/R. Compared with WT mice, Bmp3b -deficient mice developed larger MIs. Increasing functional BAT by transplanting BAT from WT mice to Bmp3b -deficient mice reduced I/R injury whereas transplanting BAT from Bmp3b -deficient mice did not. Treatment of WT mice with BMP3b before reperfusion decreased MI size. The cardioprotective effect of BMP3b was mediated through SMAD1/5/8. In humans, the plasma level of BMP3b increased after MI and was positively correlated with the extent of cardiac injury. CONCLUSIONS: The results of this study suggest a cardioprotective role of BAT and BMP3b, a protein secreted by BAT, in a model of I/R injury. Interventions increasing BMP3b levels or targeting Smad 1/5 may represent novel therapeutic approaches to decrease myocardial damage in I/R injury.


  • Open Access

    Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy

    by Laia Cañes, Ingrid Martí-Pàmies, Carme Ballester-Servera, Adela Herraiz-Martínez, Judith Alonso, María Galán, J. Francisco Nistal, Pedro Muniesa, Jesús Osada, Leif Hove-Madsen, et al.

    Hypertensive cardiac hypertrophy (HCH) is a common cause of heart failure, a major public health problem worldwide. However, the molecular bases of HCH have not been completely elucidated. Neuron-derived orphan receptor-1 (NOR-1) is a nuclear receptor whose role in cardiac remodelling is poorly understood. The aim of this study was to generate a transgenic mouse over-expressing NOR-1 in the heart (TgNOR-1) and assess the impact of this gain-of-function on HCH. The CAG promoter-driven transgenesis led to viable animals that over-expressed NOR-1 into the heart, mainly in cardiomyocytes but also in cardiofibroblasts. Cardiomyocytes from TgNOR-1 exhibited an enhanced cell surface area and Myh7/Myh6 expression ratio, and increased cell shortening elicited by electric field stimulation. TgNOR-1cardiofibroblasts expressed higher levels of myofibroblast markers than WT cells (Acta1, Sm22α) and were more prone to synthesise collagen and migrate. TgNOR-1 mice experienced an age-associated remodelling of the left ventricle. Angiotensin II (AngII) induced the cardiac expression of NOR-1, and NOR-1 transgenesis exacerbated AngII-induced cardiac hypertrophy and fibrosis. This effect was associated with the upregulation of hypertrophic (Bnp, Acta1 and Myh7) and fibrotic markers (Col1a1, Pai-1 and Loxl2). NOR-1 transgenesis upregulated two key genes involved in cardiac hypertrophy (Myh7, encoding for β-myosin heavy chain) and fibrosis (Loxl2, encoding encoding for the extracellular matrix modifying enzyme lysyl oxidase-like 2). Interestigly, in transient transfection assays, NOR-1 drove the transcription of Myh7 and Loxl2 promoters. Our findings suggest that NOR-1 is involved in the transcriptional program leading to HCH.


  • Open Access

    The nuclear receptor NOR‐1/NR4A3 regulates the multifunctional glycoprotein vitronectin in human vascular smooth muscle cells

    by Ingrid Martí‐Pàmies, Laia Cañes, Judith Alonso, Cristina Rodríguez, José Martínez‐González

    The nuclear receptor NOR‐1 (NR4A3) has recently been involved in the regulation of extracellular matrix (ECM) proteins associated with neointimal thickening and the vascular control of hemostasis. We sought to find as‐yet unidentified NOR‐1 target genes in human vascular smooth muscle cells (VSMCs). An in silico analysis identified putative NOR‐1 response elements in the proximal promoter region of several genes encoding for ECM proteins, including vitronectin (VTN). Lentiviral overexpression of NOR‐1 strongly increased VTN mRNA and protein levels, whereas NOR‐1 silencing significantly reduced VTN expression. Deletion and site‐directed mutagenesis studies, as well as EMSA and chromatin immunoprecipitation, identified the NBRE(−202/−195) site in the VTN promoter as an essential element for NOR‐1 responsiveness. Furthermore, NOR‐1 and VTN colocalized in VSMCs in human atherosclerotic lesions. VTN levels were increased in cell supernatants from VSMCs that overexpress NOR‐1. Cell supernatants from VSMCs overexpressing NOR‐1 induced cell migration to a greater extent than supernatants from control cells, and this effect was attenuated when cell supernatants were preincubated with anti‐VTN blocking antibodies or VTN was silenced in supernatant‐generating cells. These results indicate that VTN is a target of NOR‐1 and suggest that this multifunctional glycoprotein may participate in vascular responses mediated by this nuclear receptor.—Martí‐Pàmies, I., Cañes, L., Alonso, J., Rodríguez, C., Martínez‐González, J. The nuclear receptor NOR‐1/NR4A3 regulates the multifunctional glycoprotein vitronectin in human vascular smooth muscle cells. FASEB J. 31, 4588–4599 (2017). www.fasebj.org


  • Modulation of human VSMC migration by vitronectin: studies of transcriptional regulation

    by Íngrid Martí-Pàmies, Laia Cañes, Cristina Rodriguez, José Martínez-González

  • Open Access

    NOR-1/NR4A3 regulates the cellular inhibitor of apoptosis 2 (cIAP2) in vascular cells: role in the survival response to hypoxic stress

    by Judith Alonso, María Galán, Ingrid Martí-Pàmies, José María Romero, Mercedes Camacho, Cristina Rodríguez, José Martínez-González

    Vascular cell survival is compromised under pathological conditions such as abdominal aortic aneurysm (AAA). We have previously shown that the nuclear receptor NOR-1 is involved in the survival response of vascular cells to hypoxia. Here, we identify the anti-apoptotic protein cIAP2 as a downstream effector of NOR-1. NOR-1 and cIAP2 were up-regulated in human AAA samples, colocalizing in vascular smooth muscle cells (VSMC). While NOR-1 silencing reduced cIAP2 expression in vascular cells, lentiviral over-expression of this receptor increased cIAP2 mRNA and protein levels. The transcriptional regulation of the human cIAP2 promoter was analyzed in cells over-expressing NOR-1 by luciferase reporter assays, electrophoretic mobility shift analysis and chromatin immunoprecipitation, identifying a NGFI-B site (NBRE-358/-351) essential for NOR-1 responsiveness. NOR-1 and cIAP2 were up-regulated by hypoxia and by a hypoxia mimetic showing a similar time-dependent pattern. Deletion and site-directed mutagenesis studies show that NOR-1 mediates the hypoxia-induced cIAP2 expression. While NOR-1 over-expression up-regulated cIAP2 and limited VSMC apoptosis induced by hypoxic stress, cIAP2 silencing partially prevented this NOR-1 pro-survival effect. These results indicate that cIAP2 is a target of NOR-1 and suggest that this anti-apoptotic protein is involved in the survival response to hypoxic stress mediated by NOR-1 in vascular cells.


  • Open Access

    The nuclear receptor NOR-1 regulates the small muscle protein, X-linked (SMPX) and myotube differentiation

    by Beatriz Ferrán, Ingrid Martí-Pàmies, Judith Alonso, Ricardo Rodríguez-Calvo, Silvia Aguiló, Francisco Vidal, Cristina Rodríguez, José Martínez-González

    Recent works have highlighted the role of NOR-1 in both smooth and skeletal muscle and have proposed this nuclear receptor as a nexus that coordinates muscle performance and metabolic capacity. However, no muscle specific genes regulated by NOR-1 have been identified so far. To identify NOR-1 target genes, we over-expressed NOR-1 in human vascular smooth muscle cells (VSMC). These cells subjected to sustained over-expression of supraphysiological levels of NOR-1 experienced marked phenotypic changes and up-regulated the skeletal muscle protein X-linked (SMPX), a protein typically expressed in striated muscle and associated to cell shape. By transcriptional studies and DNA-protein binding assays, we identified a non-consensus NBRE site in human SMPX promoter, critical for NOR-1 responsiveness. The expression of SMPX was higher in human skeletal muscle myoblasts (HSMM) than in human VSMC and further increased in HSMM differentiated to myotubes. NOR-1 silencing prevented SMPX expression in HSMM, as well as their differentiation to myotubes, but the up-regulation of SMPX was dispensable for HSMM differentiation. Our results indicate that NOR-1 regulate SMPX in human muscle cells and acts as a muscle regulatory factor, but further studies are required to unravel its role in muscle differentiation and hypertrophy.


  • Open Access

    Down-regulation of Fibulin-5 is associated with aortic dilation: role of inflammation and epigenetics

    by Mar Orriols, Saray Varona, Ingrid Martí-Pàmies, María Galán, Anna Guadall, José Román Escudero, José Luis Martín-Ventura, Mercedes Camacho, Luis Vila, José Martínez-González, et al.

    Destructive remodelling of extracellular matrix (ECM) and inflammation lead to dilation and ultimately abdominal aortic aneurysm (AAA). Fibulin-5 (FBLN5) mediates cell–ECM interactions and elastic fibre assembly and is critical for ECM remodelling. We aimed to characterize FBLN5 regulation in human AAA and analyse the underlying mechanisms. FBLN5 expression was significantly decreased in human aneurysmatic aortas compared with healthy vessels. Local FBLN5 knockdown promoted aortic dilation and enhanced vascular expression of inflammatory markers in Ang II-infused C57BL/6J mice. Inflammatory stimuli down-regulated FBLN5 expression and transcriptional activity in human aortic vascular smooth muscle cells (VSMC). Further, aortic FBLN5 expression was reduced in LPS-challenged mice. A SOX response element was critical for FBLN5 promoter activity. The SOX9 expression pattern in human AAA parallels that of FBLN5, and like FBLN5, it was reduced in TNFα-stimulated VSMC. Interestingly, SOX9 over-expression prevented the cytokine-mediated reduction of FBLN5 expression and transcription. The inhibition of Class I histone deacetylases (HDACs) by MS-275 or gene silencing attenuated the inflammation-mediated decrease of FBLN5 expression in VSMC and in the vascular wall. Consistently, HDAC inhibition counteracted the reduction of SOX9 expression induced by inflammatory stimuli and prevented the TNFα-mediated decrease in the binding of SOX9 to FBLN5 promoter normalizing FBLN5 expression. We evidence the deregulation of FBLN5 in human AAA and identify a SOX9/HDAC-dependent mechanism involved in the down-regulation of FBLN5 by inflammation. HDAC inhibitors or pharmacological approaches that aimed to preserve FBLN5 could be useful to prevent the disorganization of ECM induced by inflammation in AAA.


  • NR4A receptors up-regulate the antiproteinase alpha-2 macroglobulin (A2M) and modulate MMP-2 and MMP-9 in vascular smooth muscle cells

    by Ricardo Rodríguez-Calvo, Beatriz Ferrán, Judith Alonso, Ingrid Martí-Pàmies, Silvia Aguiló, Olivier Calvayrac, Cristina Rodríguez, José Martínez-González

    Summary: Matrix metalloproteinases (MMPs) are associated with tissue remodelling and repair. In non-vascular tissues, NR4A receptors have been involved in the regulation of MMPs by transcriptional repression mechanisms. Here, we analyse alternative mechanisms involving NR4A receptors in the modulation of MMP activity in vascular smooth muscle cells (VSMC). Lentiviral overexpression of NR4A receptors (NOR-1, Nurr1 and Nur77) in human VSMC strongly decreased MMP-2 and MMP-9 activities (analysed by zymography and DQ-gelatin assays) and protein levels. NR4A receptors also down-regulated MMP-2 mRNA levels. Real-time PCR analysis evidenced that alpha-2-macroglobulin (A2M), but not other MMP inhibitors (TIMP-1 and TIMP-2) were up-regulated in NR4A-transduced cells. Interestingly, A2M was expressed in human vascular tissues including the smooth muscle media layer. While NR4A receptors increased A2M expression and secretion in VSMC, NR4A knockdown significantly reduced basal A2M expression in these cells. The direct transcriptional regulation of the human A2M promoter by NR4A receptors was characterised in luciferase reporter assays, electrophoretic mobility shift assays and by chromatin immunoprecipitation, identifying a NGFI-B response element (NBRE-71/-64) essential for the NR4A-mediated induction. The blockade of A2M partially prevented the reduction of MMPs activity observed in NR4A-transduced cells. Although mouse A2M promoter was unresponsive to NR4A receptors, vascular MMP expression was attenuated in transgenic mice over-expressing human NOR-1 in VSMC challenged with lipopolysaccharide. Our results show that the panproteinase inhibitor A2M is expressed in the vasculature and that NR4A receptors modulate VSMC MMP activity by several mechanisms including the up-regulation of A2M.


  • NOR-1 modulates the inflammatory response of vascular smooth muscle cells by preventing NFκB activation

    by Olivier Calvayrac, Ricardo Rodríguez-Calvo, Ingrid Martí-Pamies, Judith Alonso, Beatriz Ferrán, Silvia Aguiló, Javier Crespo, Antonio Rodríguez-Sinovas, Cristina Rodríguez, José Martínez-González